Cadenza Bio, Inc. Appoints Michael A. Panzara, MD, MPH, to its Board of Directors
Cadenza Bio announces the appointment of Dr. Michael A. Panzara, a renowned neurology expert, to its ...
Read more
Tag: MS drug pipeline
"HR Today" aspires to be more than just a publication; it aims to be a platform where the brightest minds in HR come together to share knowledge, insights, and foresight that can shape the future of our profession. We aim to offer a unique blend of academic rigour and practical wisdom, addressing the most pressing challenges and opportunities in the HR landscape today.